Relevance of Platinum-free Interval and BRCA Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for gBRCA Advanced Breast Cancer (BROCADE3 Crossover)
对于接受卡铂/紫杉醇治疗后进展的 gBRCA 晚期乳腺癌患者,铂类药物治疗间隔和 BRCA 基因逆转突变与 Veliparib 单药治疗的相关性(BROCADE3 交叉研究)
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-21-0748
Puhalla, Shannon L; Diéras, Véronique; Arun, Banu K; Kaufman, Bella; Wildiers, Hans; Han, Hyo S; Ayoub, Jean-Pierre; Stearns, Vered; Yuan, Yuan; Helsten, Teresa; Riley-Gillis, Bridget; Murphy, Erin; Kundu, Madan G; Wu, Meijing; Maag, David; Ratajczak, Christine K; Ramathal, Cyril Y; Friedlander, Michael